The multiple faces of caveolae

Nature Reviews Molecular Cell Biology

Volumn 8, Issue 3, 2007, Pages 185-194

  Parton, Robert G ^a   Simons, Kai ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; DYNAMIN; DYSFERLIN; FIBRONECTIN; GLYCOSYLPHOSPHATIDYLINOSITOL; MEMBRANE PROTEIN; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; SNARE PROTEIN;

ADIPOCYTE; CAVEOLA; CELL ADHESION; CELL FUNCTION; CELL MEMBRANE; CELL STRUCTURE; CELL SURFACE; CELL TYPE; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; EXOCYTOSIS; FIBROBLAST; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GOLGI COMPLEX; HUMAN; LIPID BILAYER; LIPID COMPOSITION; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SIMIAN VIRUS 40;

ANIMALS; CAVEOLAE; CAVEOLINS; CELL MEMBRANE; HUMANS; LIPID METABOLISM; MECHANOTRANSDUCTION, CELLULAR; MEMBRANE MICRODOMAINS;

MAMMALIA;

EID: 33847181297     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2122     Document Type: Review

References (141)

1. Palade, G.E. Fine structure of blood capillaries. J. Appl. Phys. 24, 1424 (1953).
2. Yamada, E. The fine structures of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol. 1, 445-458 (1955).
3. Stan, R.V. Structure of caveolae. Biochim. Biophys. Acta 1746, 334-348 (2005).
4. Stan, R.V., Tkachenko, E. & Niesman, I.R. PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms. Mol. Biol. Cell 15, 3615-3630 (2004).
5. Lisanti, M.P. et al. Caveolae, transmembrane signalling and cellular transformation. Mol. Membr. Biol. 12, 121-124 (1995).
6. Kurzchalia, T.V. & Parton, R.G. Membrane microdomains and caveolae. Curr. Opin. Cell Biol. 11, 424-431 (1999).
7. Williams, T.M. & Lisanti, M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell Physiol. 288, C494-C506 (2005).
8. Pelkmans, L., Kartenbeck, J. & Helenius, A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nature Cell Biol. 3, 473-483 (2001).
9. Shin, J.S., Gao, Z. & Abraham, S.N. Involvement of cellular caveolae in bacterial entry into mast cells. Science 289, 785-788 (2000).
10. Fra, A.M., Williamson, E., Simons, K. & Parton, R.G. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl Acad. Sci. USA 92, 8655-8659 (1995).
11. Drab, M. et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in Caveolin-1 gene-disrupted mice. Science 293, 2449-2452 (2001).
12. Galbiati, F. et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J. Biol. Chem. 276, 21425-21433 (2001).
13. Tang, Z. et al. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem. 271, 2255-2261 (1996).
14. Way, M. & Parton, R.G. M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett. 376, 108-112 (1995).
15. Razani, B. et al. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol. Cell. Biol. 22, 2329-2344 (2002).
16. Sowa, G., Pypaert, M., Fulton, D. & Sessa, W.C. The phosphorylation of caveolin-2 on serines 23 and 36 modulates caveolin-1-dependent caveolae formation. Proc. Natl Acad. Sci. USA 100, 6511-6516 (2003).
17. Lahtinen, U., Honsho, M., Parton, R.G., Simons, K. & Verkade, P. Involvement of caveolin-2 in caveolar biogenesis in MDCK cells. FEBS Lett. 538, 85-88 (2003).
18. Murata, M. et al. VIP21/caveolin is a cholesterol-binding protein. Proc. Natl Acad. Sci. USA 92, 10339-10343 (1995).
19. Dietzen, D.J., Hastings, W.R. & Lublin, D.M. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J. Biol. Chem. 270, 6838-6842 (1995).
20. Rothberg, K.G. et al. Caveolin, a protein component of caveolae membrane coats. Cell 68, 673-682 (1992).
21. Pelkmans, L. & Zerial, M. Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae. Nature 436, 128-133 (2005).
22. Ortegren, U. et al. Lipids and glycosphingolipids in caveolae and surrounding plasma membrane of primary rat adipocytes. Eur. J. Biochem. 271, 2028-2036 (2004). Quantification of lipid levels within caveolae shows that glycosphingolipids and cholesterol are concentrated more within caveolae compared with the surrounding plasma membrane. Higher packing of total lipids is observed in caveolae compared with the surrounding plasma membrane.
23. Schuck, S. & Simons, K. Polarized sorting in epithelial cells: raft clustering and the biogenesis of the apical membrane. J. Cell Sci. 117, 5955-5964 (2004).
24. Simons, K. & Vaz, W.L. Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33, 269-295 (2004). An extensive review of the data supporting lipid-based microdomain formation in model systems and in cell membranes.
25. Hancock, J.F. Lipid rafts: contentious only from simplistic standpoints. Nature Rev. Mol. Cell Biol. 7, 456-462 (2006).
26. Lipardi, C. et al. Caveolin transfection results in caveolae formation but not apical sorting of glycosylphosphatidylinositol (GPI)-anchored proteins in epithelial cells. J. Cell Biol. 140, 617-626 (1998).
27. Parton, R.G., Hanzal-Bayer, M. & Hancock, J.F. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J. Cell Sci. 119, 787-796 (2006). Summary of current data on caveola biogenesis and a proposed model for the formation of caveolae through caveolin-lipid interactions.
28. Monier, S. et al. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell 6, 911-927 (1995).
29. Monier, S., Dietzen, D.J., Hastings, W.R., Lublin, D.M. & Kurzchalia, T.V. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett. 388, 143-149 (1996).
30. Pol, A. et al. Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies. Mol. Biol. Cell 16, 2091-2105 (2005).
31. Cheng, Z.J. et al. Distinct mechanisms of clathrin-independent cndocytosis have unique sphingolipid requirements. Mol. Biol. Cell 17, 3197-3210 (2006).
32. Tagawa, A. et al. Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters. J. Cell Biol. 170, 769-779 (2005). Real-time microscopy and cell-fusion experiments show that caveolae are remarkably stable with evidence for formation of 'caveolae' in the Golgi complex that then fuse directly with the plasma membrane.
33. Lipowsky, R. Domain-induced budding of fluid membranes. Biophys. J. 64, 1133-1138 (1993).
34. Bauer, M. & Pelkmans, L. A new paradigm for membrane-organizing and -shaping scaffolds. FEBS Lett. 580, 5559-5564 (2006).
35. Choudhury, A., Marks, D.L., Proctor, K.M., Gould, G.W. & Pagano, R.E. Regulation of caveolar endocytosis by syntaxin 6-dependent delivery of membrane components to the cell surface. Nature Cell Biol. 8, 317-328 (2006). Identifies syntaxin-6 as a regulator of CAV1, GPI-anchored proteins, and GM1 transport from Golgi to the plasma membrane and provides insights into the coupling of exocytosis and endocytosis of lipid-raft components.
36. Manninen, A. et al. Caveolin-1 is not essential for biosynthetic apical membrane transport. Mol. Cell. Biol. 25, 10087-10096 (2005).
37. Hernandez-Deviez, D.J. et al. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. Hum. Mol. Genet. 15, 129-142 (2006).
38. Wyse, B.D. et al. Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J. Biol. Chem. 278, 23738-23746 (2003).
39. Cohen, A.W. et al. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am. J. Physiol. Cell Physiol. 285, C222-C235 (2003).
40. 2+ influx channels by regulating plasma membrane localization of TRPC1. J. Biol. Chem. 278, 27208-27215 (2003).
41. Maroto, R. et al. TRPC1 forms the stretch-activated cation channel in vertebrate cells. Nature Cell Biol. 7, 179-185 (2005).
42. Scheiffele, P. et al. Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J. Cell Biol. 140, 795-806 (1998).
43. Verkade, P., Harder, T., Lafont, F. & Simons, K. Induction of caveolae in the apical plasma membrane of Madin-Darby canine kidney cells. J. Cell Biol. 148, 727-739 (2000).
44. Pelkmans, L., Burli, T., Zerial, M. & Helenius, A. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118, 767-780 (2004).
45. Thomsen, P., Roepstorff, K., Stahlhut, M. & van Deurs, B. Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol. Biol. Cell 13, 238-250 (2002).
46. Kirkham, M. et al. Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. J. Cell Biol. 168, 465-476 (2005).
47. Pelkmans, L., Puntener, D. & Helenius, A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296, 535-539 (2002).
48. Sharma, D.K. et al. Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol. Biol. Cell 15, 3114-3122 (2004).
49. Oh, P., McIntosh, D.P. & Schnitzer, J.E. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J. Cell Biol. 141, 101-114 (1998).
50. Henley, J.R., Krueger, E.W., Oswald, B.J. & McNiven, M.A. Dynamin-mediated internalization of caveolae. J. Cell Biol. 141, 85-99 (1998).
51. Yao, Q. et al. Caveolin-1 interacts directly with dynamin-2. J. Mol. Biol. 348, 491-501 (2005).
52. Damm, E.M. et al. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168, 477-488 (2005).
53. Kirkham, M. & Parton, R.G. Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim. Biophys. Acta 1745, 273-286 (2005).
54. Nabi, I.R. & Le, P.U. Caveolae/raft-dependent endocytosis. J. Cell Biol. 161, 673-677 (2003).
55. Pelkmans, L. et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436, 78-86 (2005). A high-throughput screen of kinases involved in endocytosis provides fascinating insights into the complex interplay between endocytosis and other cellular processes, such as cell adhesion and cell division.
56. Sharma, D.K. et al. The glycosphingolipid, lactosylceramide, regulates β1-integrin clustering and endocytosis. Cancer Res. 65, 8233-8241 (2005). Evidence for glycosphingolipid-stimulated β1-integrin internalization through a caveolae-mediated pathway.
57. Sottile, J. & Chandler, J. Fibronectin matrix turnover occurs through a caveolin-1-dependent process. Mol. Biol. Cell 16, 757-768 (2005).
58. del Pozo, M.A. et al. Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nature Cell Biol. 7, 901-908 (2005). Demonstrates striking internalization of lipid-raft components upon cell detachment from the substratum through a phospho-CAV1-dependent pathway.
59. Parton, R.G. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J. Histochem. Cytochem. 42, 155-166 (1994).
60. Nichols, B.J. GM1-containing lipid rafts are depleted within clathrin-coated pits. Curr. Biol. 13, 686-690 (2003).
61. Watarai, M., Makino, S., Fujii, Y., Okamoto, K. & Shirahata, T. Modulation of Brucella-induced macropinocytosis by lipid rafts mediates intracellular replication. Cell Microbiol. 4, 341-355 (2002).
62. Minshall, R.D. et al. Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway. J. Cell Biol. 150, 1057-1070 (2000).
63. Schubert, W. et al. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J. Biol. Chem. 276, 48619-48622 (2001).
64. Miyawaki-Shimizu, K. et al. siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L405-L413 (2006). siRNA-mediated downregulation of CAV1 in vivo causes a loss of endothelial caveolae and an increase in vascular hyperpermeability to albumin. Ultrastructural studies showed dilation of interendothelial junctions.
65. Rosengren, B.I. et al. Transvascular protein transport in mice lacking endothelial caveolae. Am. J. Physiol. Heart Circ. Physiol. 291, H1371-H1377 (2006). Evidence for a passive porous pathway for transport of albumin across the endothelium in vivo in both Cav1-knockout and wild-type mice, arguing against caveolae as a quantitatively important transport route.
66. Schubert, W. et al. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J. Biol. Chem. 277, 40091-40098 (2002).
67. Sigismund, S. et al. Clathrin-independent endocytosis of ubiquitinated cargos. Proc. Natl Acad. Sci. USA 102, 2760-2765 (2005).
68. Di Guglielmo, G.M., Le Roy, C., Goodfellow, A.F. & Wrana, J.L. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nature Cell Biol. 5, 410-421 (2003).
69. Anderson, H.A., Chen, Y. & Norkin, L.C. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell 7, 1825-1834 (1996).
70. Stang, E., Kartenbeck, J. & Parton, R.G. Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol. Biol. Cell 8, 47-57 (1997).
71. Sukumaran, S.K., Quon, M.J. & Prasadarao, N.V. Escherichia coli K1 internalization via caveolae requires caveolin-1 and protein kinase Cα interaction in human brain microvascular endothelial cells. J. Biol. Chem. 277, 50716-50724 (2002).
72. Zaas, D.W., Duncan, M.J., Li, G., Wright, J.R. & Abraham, S.N. Pseudomonas invasion of type I pneumocytes is dependent on the expression and phosphorylation of caveolin-2. J. Biol. Chem. 280, 4864-4872 (2005).
73. Tamai, R., Asai, Y. & Ogawa, T. Requirement for intercellular adhesion molecule 1 and caveolae in invasion of human oral epithelial cells by Porphyromonas gingivalis. Infect. Immun. 73, 6290-6298 (2005).
74. Rohde, M., Muller, E., Chhatwal, G.S. & Talay, S.R. Host cell caveolae act as an entry-port for group A streptococci. Cell. Microbiol. 5, 323-342 (2003).
75. Millan, J. et al. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nature Cell Biol. 8, 113-123 (2006).
76. Muro, S. et al. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J. Cell Sci. 116, 1599-1609 (2003).
77. Li, J. et al. Impaired phagocytosis in caveolin-1 deficient macrophages. Cell Cycle 4, 1599-1607 (2005).
78. Beardsley, A. et al. Loss of caveolin-1 polarity impedes endothelial cell polarization and directional movement. J. Biol. Chem. 280, 3541-3547 (2005). Provides evidence for a functional role for CAV1 in endothelial-cell motility. In actively migrating cells, caveolae are localized at the rear of the cell and excluded from the leading edge.
79. Souto, R.P. et al. Immunopurification and characterization of rat adipocyte caveolae suggest their dissociation from insulin signaling. J. Biol. Chem. 278, 18321-18329 (2003).
80. Li, S., Couet, J. & Lisanti, M.P. Src tyrosine kinases, Gα subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem. 271, 29182-29190 (1996).
81. Schlegel, A., Schwab, R.B., Scherer, P.E. & Lisanti, M.P. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro. J. Biol. Chem. 274, 22660-22667 (1999).
82. Epand, R.M., Sayer, B.G. & Epand, R.F. Caveolin scaffolding region and cholesterol-rich domains in membranes. J. Mol. Biol. 345, 339-350 (2005).
83. Arbuzova, A. et al. Membrane binding of peptides containing both basic and aromatic residues. Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS. Biochemistry 39, 10330-10339 (2000).
84. Gonzalez, E., Nagiel, A., Lin, A.J., Golan, D.E. & Michel, T. Small interfering RNA-mediated downregulation of caveolin-1 differentially modulates signaling pathways in endothelial cells. J. Biol. Chem. 279, 40659-40669 (2004).
85. Bernatchez, P.N. et al. Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proc. Natl Acad. Sci. USA 102, 761-766 (2005).
86. Wary, K.K., Mariotti, A., Zurzolo, C. & Giancotti, F.G. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94, 625-634 (1998).
87. Bauer, P.M. et al. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc. Natl Acad. Sci. USA 102, 204-209 (2005). Transgenic overexpression of CAV1 impairs eNOS activation and decreases VEGF-stimulated vascular permeability. CAV1 overexpression reduced VEGF-mediated angiogenesis after experimentally induced tissue ischaemia.
88. Bucci, M. et al. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nature Med. 6, 1362-1367 (2000).
89. Garcia-Cardena, G. et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J. Biol. Chem. 272, 25437-25440 (1997).
90. Reddy, M.A. et al. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J. Biol. Chem. 281, 13685-13693 (2006).
91. Swaney, J.S. et al. Focal adhesions in (myo)fibroblasts scaffold adenylyl cyclase with phosphorylated caveolin. J. Biol. Chem. 281, 17173-17179 (2006).
92. 2+ spark coupling in murine arterial smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 290, H2309-H2319 (2006).
93. + channels in vascular endothelial cells. J. Biol. Chem. 280, 11656-11664 (2005).
94. Trigatti, B.L., Anderson, R.G. & Gerber, G.E. Identification of caveolin-1 as a fatty acid binding protein. Biochem. Biophys. Res. Commun. 255, 34-39 (1999).
95. Martin, S. & Parton, R.G. Lipid droplets: a unified view of a dynamic organelle. Nature Rev. Mol. Cell Biol. 7, 373-378 (2006).
96. Murphy, D.J. The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog. Lipid Res. 40, 325-438 (2001).
97. Martin, S. & Parton, R.G. Caveolin, cholesterol, and lipid bodies. Semin. Cell Dev. Biol. 16, 163-174 (2005).
98. Brasaemle, D.L., Dolios, G., Shapiro, L. & Wang, R. Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J. Biol. Chem. 279, 46835-46842 (2004).
99. Pol, A. et al. Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant. Mol. Biol. Cell 15, 99-110 (2004).
100. Meshulam, T., Simard, J.R., Wharton, J., Hamilton, J.A. & Pilch, P.F. Role of caveolin-1 and cholesterol in transmembrane fatty acid movement. Biochemistry 45, 2882-2893 (2006).
101. Fu, Y. et al. Expression of caveolin-1 enhances cholesterol efflux in hepatic cells. J. Biol. Chem. 279, 14140-14146 (2004).
102. Fielding, C.J. & Fielding, P.E. Caveolae and intracellular trafficking of cholesterol. Adv. Drug Deliv. Rev. 49, 251-264 (2001).
103. Frank, P.G. et al. Caveolin-1 and the regulation of cellular cholesterol homeostasis. Am. J. Physiol. Heart Circ. Physiol. 291, H677-H686 (2006).
104. Pol, A. et al. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J. Cell Biol. 152, 1057-1070 (2001).
105. Fernandez, M.A. et al. Caveolin-1 is essential for liver regeneration. Science 313, 1628-1632 (2006).
106. Razani, B. et al. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J. Biol. Chem. 277, 8635-8647 (2002).
107. Le Lay, S. et al. Cholesterol-induced caveolin targeting to lipid droplets in adipocytes: a role for caveolar endocytosis. Traffic 7, 549-561 (2006).
108. Landh, T. From entangled membranes to eclectic morphologies: cubic membranes as subcellular space organizers. FEBS Lett. 369, 13-17 (1995).
109. Vogel, V. & Sheetz, M. Local force and geometry sensing regulate cell functions. Nature Rev. Mol. Cell Biol. 7, 265-275 (2006).
110. Rizzo, V., Morton, C., DePaola, N., Schnitzer, J.E. & Davies, P.F. Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am. J. Physiol. Heart Circ. Physiol. 285, H1720-H1729 (2003). In cultured endothelial cells, chronic exposure to shear stress causes increased surface localization of CAV1 and caveolae; this effect is linked to increased mechanosensitivity and activation of specific signalling pathways.
111. Boyd, N.L. et al. Chronic shear induces caveolae formation and alters ERK and Akt responses in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 285, H1113-H1122 (2003).
112. Radel, C. & Rizzo, V. Integrin mechanotransduction stimulates caveolin-1 phosphorylation and recruitment of Csk to mediate actin reorganization. Am. J. Physiol. Heart Circ. Physiol. 288, H936-H945 (2005). Cultured bovine aortic endothelial cells subjected to shear stress show rapid Tyr14 phosphorylation of CAV1, which is dependent on β1-integrin activation, supporting a role for caveolae in mechanosensing.
113. Yu, J. et al. Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J. Clin. Invest. 116, 1284-1291 (2006). Endothelial expression of CAV1 in Cav1-null mice shows that CAV1 is required for eNOS activation in response to endothelial flow; these data provide further support for a mechanosensing role of caveolae.
114. Rudic, R.D. et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 101, 731-736 (1998).
115. Sedding, D.G. et al. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ. Res. 96, 635-642 (2005). Smooth-muscle cells subjected to cyclic stretch show rapid redistribution of CAV1 to focal contacts. CAV1 is required for stretch-triggered cell-cycle progression.
116. s target lipid rafts by default. Mol. Biol. Cell 12, 685-698 (2001).
117. Czarny, M. & Schnitzer, J.E. Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium. Am. J. Physiol. Heart. Circ Physiol. 287, H1344-H1352 (2004).
118. Alenghat, F.J. & Ingber, D.E. Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci. STKE 2002, PE6 (2002).
119. Lundbaek, J.A. et al. Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of micelle-forming amphiphiles and cholesterol. J. Gen. Physiol. 123, 599-621 (2004).
120. Lundbaek, J.A., Andersen, O.S., Werge, T. & Nielsen, C. Cholesterol-induced protein sorting: an analysis of energetic feasibility. Biophys. J. 84, 2080-2089 (2003).
121. Sens, P. & Turner, M.S. Budded membrane microdomains as tension regulators. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 73, 031918 (2006).
122. Koleske, A.J., Baltimore, D. & Lisanti, M.P. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl Acad. Sci. USA 92, 1381-1385 (1995).
123. Lee, S.W., Reimer, C.L., Oh, P., Campbell, D.B. & Schnitzer, J.E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16, 1391-1397 (1998).
124. Hayashi, K. et al. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res. 61, 2361-2364 (2001).
125. Williams, T.M. et al. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Mol. Biol. Cell 14, 1027-1042 (2003).
126. Capozza, F. et al. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am. J. Pathol. 162, 2029-2039 (2003).
127. Li, T. et al. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor α-positive status. Am. J. Pathol. 168, 1998-2013 (2006).
128. Sunaga, N. et al. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res. 64, 4277-4285 (2004).
129. Thompson, T.C., Timme, T.L., Li, L. & Goltsov, A. Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer. Apoptosis 4, 233-237 (1999).
130. Yang, G., Timme, T.L., Frolov, A., Wheeler, T.M. & Thompson, T.C. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Cancer 103, 1186-1194 (2005).
131. Vorgerd, M. et al. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 57, 2273-2277 (2001).
132. McNally, E.M. et al. Caveolin-3 in muscular dystrophy. Hum. Mol. Genet. 7, 871-877 (1998).
133. Woodman, S.E., Sotgia, F., Galbiati, F., Minetti, C. & Lisanti, M.P. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology 62, 538-543 (2004).
134. Minetti, C. et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nature Genet. 18, 365-368 (1998).
135. Galbiati, F., Volonte, D., Minetti, C., Chu, J.B. & Lisanti, M.P. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. J. Biol. Chem. 274, 25632-25641 (1999).
136. Matsuda, C. et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum. Mol. Genet. 10, 1761-1766 (2001).
137. Parton, R.G., Molero, J.C., Floetenmeyer, M., Green, K.M. & James, D.E. Characterization of a distinct plasma membrane macrodomain in differentiated adipocytes. J. Biol. Chem. 277, 46769-46778 (2002).
138. Foster, L.J., De Hoog, C.L. & Mann, M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc. Natl Acad. Sci. USA 100, 5813-5818 (2003).
139. Nixon, S.J. et al. Zebrafish as a model for caveolinassociated muscle disease; caveolin-3 is required for myofibril organization and muscle cell patterning. Hum. Mol. Genet. 14, 1727-1743 (2005).
140. Ohsawa, Y. et al. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity. Hum. Mol. Genet. 13, 151-157 (2004).
141. Sharma, D.K. et al. Glycosphingolipids internalized via caveolar-related endocytosis rapidly merge with the clathrin pathway in early endosomes and form microdomains for recycling. J. Biol. Chem. 278, 7564-7572 (2003).